Tuberculosis Research Unit (TRU)

The Tuberculosis Research Unit (TRU) is a collaborative research initiative focused on understanding and combating tuberculosis (TB), a serious infectious disease that primarily affects the lungs. TRU engages scientists, clinicians, and public health experts to study TB's biology, transmission, and treatment options. By conducting clinical trials and developing new therapies and vaccines, the unit aims to reduce the burden of TB worldwide, especially in high-risk populations. The TRU also emphasizes improving diagnostics and understanding drug-resistant strains of TB to enhance prevention and treatment strategies effectively.